Ms Ritu Laddha, Sr VP & Cluster Head, Zydus Lifesciences

Speaker in this video:
Ms Ritu Laddha, Sr VP & Cluster Head, Zydus Lifesciences

Topic: Reimagining pain therapy: Oral-to-intranasal product innovation

Key Highlights:
[1] Intranasal drug delivery can provide much faster pain relief than oral medicines. Zydus developed an intranasal version of Cyclobenzaprine to improve speed and patient outcomes. 

[2] Preclinical studies and human studies showed significantly faster absorption and higher drug exposure with the nasal formulation.

[3] The innovation demonstrated strong efficacy, good tolerability, and patent potential for next-generation pain therapy.